The National Organization for Rare Disorders (NORD) over 1200 disease reports

Over 1200 Disease Reports
Not a Subscriber Yet?
         Details
Here


Database Subscriptions

Many libraries, schools, universities, and hospitals subscribe to NORD’s Rare Disease Database for unlimited access to reports on more than 1,200 diseases.

Index of Rare Diseases

This is the list of diseases currently covered in the Rare Disease Database.

Rare Disease Database

Search this database for reports on more than 1,200 diseases.

View sample report

Index of Organizations

This is the list of organizations in NORD’s Organizational Database.

Organizational Database

Read about more than 2,000 patient organizations and other sources of help.

NORD's
Washington Office

NORD's Washington OfficeRead about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.

 

Programs & Services

NORD’s Patient Assistance Programs

Since 1987, NORD has administered programs to assist uninsured or under-insured individuals in securing life-saving or life-sustaining medications. In addition to the estimated 50 million Americans who have no health insurance, an increasing number of insured individuals have policies that do not reimburse for prescription drugs. Others have policies with low annual caps on prescription drug expenditures.

NORD works closely with humanitarian-minded pharmaceutical and biotechnology companies to ensure that certain vital medications are available to those individuals whose income is too high to qualify for Medicaid but too low to pay for their prescribed medications. NORD’s programs have set the standards for fairness, equity, and unbiased eligibility. The NORD programs have gained respect from the patient communities, pharmaceutical companies, healthcare professionals, government officials, and the public. Participants have assurance that NORD protects their confidentiality. There is no conflict of interest with respect to NORD’s eligibility decisions.

* * * * *

PKU Medical Foods Assistance Program is currently closed

NORD Medical Foods Assistance Program for Patients with Phenylketonuria (PKU)

The National Organization for Rare Disorders (NORD) Medical Foods Assistance Program for Patients with Phenylketonuria (PKU) is now accepting applications for financial support. The program is a new safety net that provides financial support for PKU patients without benefit coverage to obtain their preferred medical food (limited to amino acid modified products that contain a synthetic source of protein and exclude phenylalanine). Funding is limited and patients must meet the following criteria:

  • Diagnosis of PKU via written attestation by physician
  • Residents of the United States and its territories
  • Documentation demonstrating exhaustion of available state assistance and/or denial of insurance coverage for medical foods
  • Income up to 500% of Federal Poverty Level (based on family size)

To apply for the program, please download this form, fill it out, and fax it to 203-798-2964, or mail it to:

NORD
55 Kenosia Avenue
Danbury, CT 06813

To obtain more information on the NORD Medical Foods (PKU) Program, call 1-877-798-8716.

* * * * *

Currently, NORD administers programs for:

  • Acorda Therapeutics
    Zanaflex Capsules™ Uninsured Individual Program
    (Tizanidine Hydrochloride)
    Conditions:
    Spasticity
    Contact:
    Reimbursement Assistance Program at 1-800-464-0097

  • ATON PHARMA
    ATON PHARMA Patient Assistance Program
    Cuprimine, Demser, Edecrin, Lacrisert, Mephyton, Syprine
    Conditions:
    Wilson’s Disease, Rheumatoid Arthritis, Cystinuria, pheochromocytoma, edema associated with congestive heart failure, cirrhosis of the liver, renal disease, idiopathic edema, lymphedema; dry eye syndromes, vitamin k deficiency
    Contact:
    The ATON Call Center toll-free at 1-877-286-6549

  • BioMarin Pharmaceuticals
    Naglazyme Premium/Co-Payment Assistance Program For Privately Insured Individuals
    (galsulfase)
    Conditions:
    Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Contact:
    1-800-999-6673

  • Medtronic, Inc.
    ITB® Therapy Patient Assistance Program
    Lioresal® Intrathecal (baclofen injection)
    Conditions:
    Severe spasticity
    Contact:
    NORD at 1-800-999-6673

  • Questcor Pharmaceuticals, Inc.
    ACTHAR® GEL Patient Assistance Program
    (ACTH)
    Conditions:
    Infantile spasms, multiple sclerosis, Crohns disease, Adrenal insufficiency, etc.
    Contact:
    Acthar Support & Access Program at 1-888-435-2284

  • Rare Disease Therapeutics, Inc.
    CYSTADANE® Patient Assistance Program
    (betaine anhydrous for oral solution)
    Conditions:
    Homocystinuria
    Contact:
    NORD at 1-800-999-6673

  • Rare Disease Therapeutics, Inc.
    ORFADIN® Patient Assistance Program
    (nitisinone)
    Conditions:
    Hereditary Tyrosinemia Type I
    Contact:
    NovaFactor at 1-888-454-8860

  • Sanofi - Aventis
    RILUTEK® Patient Assistance Program
    (riluzole)
    Conditions:
    Amyotrophic lateral sclerosis
    Contact:
    NORD at 1-800-459-7599

  • Sigma-tau Pharmaceuticals, Inc.
    CARNITOR® Drug Assistance Program
    (L-Carnitine or levo carnitine)
    Conditions:
    Primary systemic carnitine deficiency, dialysis, chronic fatigue syndrome (CFS), several rare metabolic disorders
    Contact:
    NORD at 1-800-999-6673

  • Sigma-tau Pharmaceuticals, Inc.
    MATULANE® Drug Assistance Program
    (procarbazine hydrochloride)
    Conditions:
    Hodgkins disease (Stage III and IV) and certain other lymphomas
    Contact:
    NORD at 1-800-999-6673

  • Teva Neuroscience, Inc.
    COPAXONE® Medication Assistance Program
    (glatiramer acetate, for injection)
    Conditions:
    Multiple sclerosis (relapsing-remitting)
    Contact:
    Shared Solutions at 1-800-887-8100

  • Teva Pharmaceuticals Inc. USA
    Tev-Tropin® Patient Assistance Program
    Tev-Tropin® Co-Payment Assistance Program For Privately Insured Individuals
    Somatropin (rDNAorigin) for injection
    Conditions:
    growth failure due to inadequate secretion of normal endogenous growth hormone
    Contact:
    Growth Solutions at 1-866-838-8767

  • Ucyclyd Pharma, Inc.
    BUPHENYL®
    (sodium phenylbuterate)
    Conditions:
    Urea cycle disorders
    Contact:
    Ucyclyd Reimbursement Hotline at 1-800-711-0811


  • ********************

  • NORD Advanced Renal Cell Carcinoma Co-Payment Assistance Program
    Conditions:

    ( NO LONGER ACCEPTING NEW APPLICATIONS )


    Advanced Renal Cell Carcinoma
    Contact:
    1-866-828-8902

  • NORD CAPS Premium & Co-payment Assistance Fund
    Conditions:
    Cryopyrin-associated periodic syndromes
    Contact:
    1-800-999-6673 x 1224

  • NORD Chronic Non-Infectious Uveitis Co-Payment Assistance Fund
    Conditions:
    Non-infectious uveitis
    Contact:
    1-800-999-6673

  • NORD Cervical Dystonia Co-Payment Assistance Program
    Conditions:
    Cervical Dystonia (Spasmodic Torticollis)
    Contact:
    1-800-999-6673 x 1311

  • NORD Cytomegalovirus (CMV) Co-Payment Assistance Program
    Conditions:
    Cytomegalovirus (CMV)
    Contact:
    1-800-999-6673

  • PROGRAM CLOSED

    NORD Hepatocellular Carcinoma Co-Payment Assistance Program

    Conditions:
    Hepatocellular Carcinoma
    Contact: 1-866-828-8902

  • NORD Hodgkins Lymphoma Co-Payment Assistance Program
    Conditions:
    Hodgkins Lymphoma
    Contact:
    1-800-999-6673

  • NORD Hunter Syndrome (MPS II) Premium/Co-Payment Assistance Program
    Conditions:
    Hunter Syndrome (MPS II)
    Contact:
    1-800-999-6673

  • NORD Infantile Spasms Premium/Co-Payment Assistance Program
    Conditions:
    Infantile spasms/West Syndrome
    Contact:
    NORD at 1-888-435-2284

  • NORD Intrathecal Therapy for Pain Management Co-Payment Assistance Program
    Conditions:
    Intrathecal Therapy for Pain Management
    Contact:
    1-888-774-2581

  • NORD Macular Edema Associated with Retinal Vein Occlusion Co-Payment Assistance Program
    Conditions:
    Macular Edema Associated with Retinal Vein Occlusion
    Contact:
    1-800-999-6673

  • NORD Marathon Pharmaceuticals Financial Relief Programs
    Conditions:
    Severe Diarrhea
    Short Term Sleep Disorders
    Contact:
    1-800-999-6673

  • NORD MPS VI Premium/Co-Payment Assistance Program
    Conditions:
    mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome)
    Contact:
    1-800-999-6673

  • NORD MS Premium /Co-Payment Assistance Program
    Conditions:
    Multiple Sclerosis (MS)
    Contact:
    1-800-634-7207

  • NORD MS Related Acute Exacerbation Premium/Co-Payment Assistance Program
    Conditions:
    MS related acute exacerbation
    Contact: 1-888-435-2284

  • NORD Nephrotic Syndrome Premium/Co-Payment Assistance Program
    Condition:
    Nephrotic Syndrome
    Contact:
    1-888-435-2284

  • NORD Opsoclonus Myoclonus Premium/Co-Payment Assistance Program
    Conditions:
    Opsoclonus Myoclonus
    Contact: NORD at 1-888-435-2284

  • NORD Peripheral T-cell Lymphoma Co-Payment Assistance Program
    Conditions:
    Peripheral T-cell Lymphoma
    Contact:
    1-877-805-0411

  • NORD Phenylketonuria (PKU) Premium/Co-Payment Assistance Program
    Conditions:
    Phenylketonuria
    Contact: 1-866-924-0100

  • NORD PNH Premium/Co-Payment Assistance Program
    Conditions:
    Paroxysmal Nocturnal Hemoglobinuria
    Contact: 1-800-999-6673

  • NORD Spasticity Intrathecal Drug Delivery Therapy Co-Payment Assistance Program
    Conditions:
    Spasticity
    Contact:
    1-800-999-6673

NORD also administers Early Access Programs for investigational new drugs (INDs) under the Food and Drug Administration’s approved “Treatment-IND” programs that allow for a limited number of individuals to receive certain investigational drugs prior to FDA marketing approval, as well as a Travel Assistance Program that provides travel and lodging assistance for patients participating in clinical and research studies.

For information about the programs listed on this page, please use the contact information associated with that particular program or write to: PatientAssistance@rarediseases.org.

Enter your name and e-mail address if you would like to receive "News Blasts" from NORD






ABOUT | CONTACT NORD


Help NORD improve the lives of people with rare diseases.

Since 1983, working toward the prevention, treatment, and cure of rare “orphan” diseases.

NORD Resource Guide

The NORD Resource Guide

The new and expanded NORD Resource Guide (5th edition) is now available. It lists more than 1,300 organizations helping people with rare disorders.

Travel Assistance

For information about free or low-cost travel to treatment facilities or sites of clinical studies, NORD refers patients and families to the National Patient Travel Center.

National Patient Travel Center

Become a NORD Member

As a member of NORD, you’ll receive benefits in addition to the satisfaction of knowing you’re helping people with rare diseases. Read about our levels of Membership and the benefits of each.

ABOUT NORD .|. CONTACT NORD .|. MEMBERSHIP .|. PRIVACY POLICY .|. DISCLAIMER .|. HOME
©2009 NORD - National Organization for Rare Disorders, Inc. All rights reserved.

Last modified Friday, January 30, 2009